$421.31
-2.65-0.63%
At Close: -
$421.31
00.00%
After Hours: Jul 19, 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Medpace Hldgs
MEDPNASDAQ
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Medpace Hldgs (NASDAQ:MEDP) Stock, Analyst Ratings, Price Targets, Forecasts
Medpace Holdings Inc has a consensus price target of $449.29 based on the ratings of 7 analysts. The high is $480 issued by UBS on March 8, 2024. The low is $395 issued by Deutsche Bank on March 18, 2024. The 3 most-recent analyst ratings were released by Baird, TD Cowen, and Mizuho on July 8, 2024, May 29, 2024, and May 28, 2024, respectively. With an average price target of $452 between Baird, TD Cowen, and Mizuho, there's an implied 7.28% upside for Medpace Holdings Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Baird
TD Cowen
Mizuho
Guggenheim
Jefferies
1calculated from analyst ratings
Analyst Ratings for Medpace Hldgs
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/08/2024 | Buy Now | 11.32% | Baird | Eric Coldwell | $456 → $469 | Maintains | Outperform | Get Alert |
| 05/29/2024 | Buy Now | 7.28% | TD Cowen | Charles Rhyee | → $452 | Initiates | → Buy | Get Alert |
| 05/28/2024 | Buy Now | 3.25% | Mizuho | Ann Hynes | → $435 | Initiates | → Buy | Get Alert |
| 04/24/2024 | Buy Now | 10.13% | Guggenheim | Sandy Draper | $453 → $464 | Maintains | Buy | Get Alert |
| 04/24/2024 | Buy Now | 7.76% | Baird | Eric Coldwell | $446 → $454 | Maintains | Outperform | Get Alert |
| 04/23/2024 | Buy Now | 6.81% | Jefferies | David Windley | $340 → $450 | Upgrade | Hold → Buy | Get Alert |
| 03/18/2024 | Buy Now | -6.24% | Deutsche Bank | Justin Bowers | → $395 | Initiates | → Hold | Get Alert |
| 03/08/2024 | Buy Now | 13.93% | UBS | John Sourbeer | $452 → $480 | Maintains | Buy | Get Alert |
| 02/15/2024 | Buy Now | 7.28% | UBS | John Sourbeer | $282 → $452 | Upgrade | Neutral → Buy | Get Alert |
| 02/14/2024 | Buy Now | -3.16% | Baird | Eric Coldwell | $312 → $408 | Maintains | Outperform | Get Alert |
| 01/17/2024 | Buy Now | -25.95% | Baird | Eric Coldwell | $302 → $312 | Maintains | Outperform | Get Alert |
| 10/24/2023 | Buy Now | -31.4% | Baird | Eric Coldwell | $270 → $289 | Upgrade | Neutral → Outperform | Get Alert |
| 07/25/2023 | Buy Now | -35.2% | Guggenheim | Sandy Draper | $252 → $273 | Maintains | Buy | Get Alert |
| 05/08/2023 | Buy Now | -40.19% | Guggenheim | Sandy Draper | → $252 | Upgrade | Neutral → Buy | Get Alert |
| 02/15/2023 | Buy Now | -44.7% | Baird | Eric Coldwell | $226 → $233 | Maintains | Neutral | Get Alert |
| 10/27/2022 | Buy Now | — | UBS | John Sourbeer | — | Upgrade | Sell → Neutral | Get Alert |
| 10/26/2022 | Buy Now | -48.49% | Baird | Eric Coldwell | $200 → $217 | Maintains | Neutral | Get Alert |
| 09/07/2022 | Buy Now | -66.3% | UBS | John Sourbeer | → $142 | Initiates | → Sell | Get Alert |
| 05/24/2022 | Buy Now | — | Guggenheim | Sandy Draper | — | Initiates | → Neutral | Get Alert |
FAQ
What is the target price for Medpace Hldgs (MEDP) stock?
The latest price target for Medpace Hldgs (NASDAQ:MEDP) was reported by Baird on July 8, 2024. The analyst firm set a price target for $469.00 expecting MEDP to rise to within 12 months (a possible 11.32% upside). 13 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Medpace Hldgs (MEDP)?
The latest analyst rating for Medpace Hldgs (NASDAQ:MEDP) was provided by Baird, and Medpace Hldgs maintained their outperform rating.
When was the last upgrade for Medpace Hldgs (MEDP)?
The last upgrade for Medpace Holdings Inc happened on April 23, 2024 when Jefferies raised their price target to $450. Jefferies previously had a hold for Medpace Holdings Inc.
When was the last downgrade for Medpace Hldgs (MEDP)?
There is no last downgrade for Medpace Hldgs.
When is the next analyst rating going to be posted or updated for Medpace Hldgs (MEDP)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Medpace Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Medpace Hldgs was filed on July 8, 2024 so you should expect the next rating to be made available sometime around July 8, 2025.
Is the Analyst Rating Medpace Hldgs (MEDP) correct?
While ratings are subjective and will change, the latest Medpace Hldgs (MEDP) rating was a maintained with a price target of $456.00 to $469.00. The current price Medpace Hldgs (MEDP) is trading at is $421.31, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.